PTGX

PROTAGONIST THERAPEUTICS INC

Healthcare | Mid Cap

-$0.67

EPS Forecast

$4.75

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Market expectations

EPS Expectation:

-$0.67

Revenue Expectation:

$4.75

EPS Surprise Expectation:

-$0.021

Revenue Surprise Expectation:

-$0

Post-release price volatility - Medium

Post-release Overnight Move:

±6.8%

Post-release 1-week Move:

±

Expected price impact

If company results match EPS & revs consensus exactly:

0.7%

If company results match Proximilar expectations exactly:

0.5%

Earnings volatility

EPS standard deviation:

$0.27

Revenue standard deviation:

$30

As % of share price:

0.27% MEDIUM

As % of market cap:

0.46% MEDIUM